Clinical efficacy of hydroxyzine hydrochloride in combination with haloperidol in the management of nausea induced by continuous infusion of opioids
10.2512/jspm.1.101
- VernacularTitle:オピオイド投与時の嘔気予防としてのハロペリドール， 塩酸ヒドロキシジン併用の有用性
- Author:
Keisuke Kaneishi
;
Naoki Matsuo
;
Kinomi Yomiya
- Publication Type:Journal Article
- Keywords:
Nausea;
Hydroxyzine Hydrochloride;
Opioid;
Aversive effect;
Haloperidol
- From:Palliative Care Research
2006;1(1):101-108
- CountryJapan
- Language:Japanese
-
Abstract:
Purpose: Nausea is a common distressing symptom experienced by advanced cancer patients. This study compared the clinical efficacy of haloperidol to hydroxyzine hydrochloride in combination with haloperidol in the management of nausea induced by continuous infusion of opioids. Methods: This retrospective study comprised 50 advanced cancer patients using continuous infusion of opioids who had been administered either haloperidol alone (haloperidol group) or hydroxyzine hydrochloride with haloperidol (hydroxyzine hydrochloride group); their nausea and characteristics were assessed using multivariate analysis. Results: After the continuous infusion of opioids, nausea occurred in 34% patients in the haloperidol group and 10% patients in the hydroxyzine hydrochloride group. No significant differences were observed in patient characteristics, except for the number of the patients using infusion of opioids. By multivariate analysis, nausea before using continuous infusion of opioids, ileus, and haloperidol without hydroxyzine hydrochloride were extracted as the risk factors of nausea. In both the groups, nausea occurred only in the patients using morphine; nausea occurred in 32.5% patients in the haloperidol group and in 4.5% patients in the hydroxyzine hydrochloride group. Conclusion: Hydroxyzine hydrochloride in combination with haloperidol was observed to be more effective than haloperidol alone in the management of nausea induced by continuous infusion of opioids.
